The Role of CXCL13 and CXCL9 in Early Breast Cancer.
Title | The Role of CXCL13 and CXCL9 in Early Breast Cancer. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Razis, E., Kalogeras K. T., Kotsantis I., Koliou G-A., Manousou K., Wirtz R., Veltrup E., Patsea H., Poulakaki N., Dionysopoulos D., Pervana S., Gogas H., Koutras A., Pentheroudakis G., Christodoulou C., Linardou H., Pavlakis K., Koletsa T., Pectasides D., Zagouri F., & Fountzilas G. |
Journal | Clin Breast Cancer |
Volume | 20 |
Issue | 1 |
Pagination | e36-e53 |
Date Published | 2020 02 |
ISSN | 1938-0666 |
Abstract | BACKGROUND: Chemokines, cytokines in the immune microenvironment of tumors, may be associated with patient outcome. We assessed the impact of CXCL13 and CXCL9 on disease-free (DFS) and overall survival (OS), in an attempt to retrospectively evaluate both T and B cell function in the microenvironment of primary tumors from patients with breast cancer. |
DOI | 10.1016/j.clbc.2019.08.008 |
Alternate Journal | Clin Breast Cancer |
PubMed ID | 31699671 |